{
  "docId": "019dd923-622c-750b-8b9a-ad0811d3e80d",
  "docSlug": "dfcef8f28a20",
  "documentTitle": "Accelerate Diagnostics (AXDX)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-09-16 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 1,
  "pageCount": 41,
  "prevPage": null,
  "nextPage": 2,
  "slideType": "thesis_headline",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "This is a short-seller research note cover page.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": "https://imgproxy.kitesheet.com/DFuVZGyK1W18s90oPFDIPCiJJU6Gkuof2tCrP2Amm54/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZmNlZjhmMjhhMjAvcDAwMS5wbmc",
  "slideHref": "/slides/019dd923-622c-750b-8b9a-ad0811d3e80d/1",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d#slide-1",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "White Diamond’s New Findings will prove why AXDX’s Pheno system is unlikely to realize the revenue the street is expecting. The issues we have found have been missed by most.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b39f-caa15f68f685",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.1,
        "x": 0.1,
        "y": 0.88
      },
      "kind": "image",
      "text": "White Diamond Research logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c79dddc7-ce5c-4941-bcca-021e952d74d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.8,
        "x": 0.1,
        "y": 0.18
      },
      "kind": "list",
      "text": "White Diamond's proprietary diligence identified new info that suggests Accelerate Diagnostic's (AXDX) Pheno system is only a niche product. The Pheno system is not capable of replacing tissue culture methods due to design flaws and a questionable value proposition. Management has missed its reagent revenues per system target by over 30% and no one is talking about it. Pheno system lease agreements do not penalize hospitals for low test volumes, which hurts annuity revenues and AXDX eats the cost for upfront installation and validation. Highly anticipated results of the upcoming Mayo/UCLA study will likely be a bust, revealing no statistically significant improvement in LOS (Length of Stay) or patient mortality.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7319e32-db70-40c9-8bbd-d989a3ae02de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "price target: $6",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b39f-cd5dc03fc925",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.8,
        "x": 0.1,
        "y": 0.67
      },
      "kind": "paragraph",
      "text": "Accelerate Diagnostics (AXDX) is a rapid diagnostic company that relies on one product, the Pheno system, utilizing PhenoTest diagnostic panels. The stock has been up over 70% in the year which we believe has created a very juicy shorting opportunity. What amazes us is that despite the continuous rise in stock price, the company has continued to miss earnings and other important metrics over the past year. We then dug deeper to figure out the fundamentals of the company and quickly realized that AXDX is selling a flawed product that is disputed by many stakeholders/professionals in the industry, and that their recent change in business model from a capital sale to a rental model will not save them from their fundamental issues: slow traction, sales and adoption rates. This information has not been realized by the market yet.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fde8499b-6251-40c1-83f3-7b865ad7e26e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.35,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Copyright 2019 White Diamond Research research@whitediamondresearch.com",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84860bf6-05ec-4de1-8766-9c70ebd88f9f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.1,
        "y": 0.55
      },
      "kind": "title",
      "text": "White Diamond's New Findings will prove why AXDX's Pheno system is unlikely to realize the revenue the street is expecting. The issues we have found have been missed by most.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0d936b5-8c90-4037-85ad-7f6fdecf8d23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.1,
        "y": 0.08
      },
      "kind": "title",
      "text": "Accelerate Diagnostics (AXDX) Is About To Accelerate Downward- $6 Price Target",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "92f4e7bb-8b46-4f72-9503-fdfccdc4ecaa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": "https://imgproxy.kitesheet.com/_AK1jvOWOYVzKo25Ywjp6vnQP7ZRdqbTDe7C6BFIPCM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZmNlZjhmMjhhMjAvcDAwMS5qcGc",
  "thumbSrc": "https://imgproxy.kitesheet.com/Tdai9KSCx4CETi7PiZMcL1EePnZZ5vvP1pNlMQEqLR4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZmNlZjhmMjhhMjAvcDAwMS5wbmc",
  "thumbSrcAlt": "https://imgproxy.kitesheet.com/Tdlv4VQfS41qdu3qW44-rSIeFd9ekJj3MSx1muE2iyw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kZmNlZjhmMjhhMjAvcDAwMS5qcGc"
}